JAMES D. WHALEN, MD

Plain English
Researchers studied a rare condition called activated phosphoinositide 3-kinase delta syndrome (APDS), which causes serious immune system issues and can lead to cancer. They looked at data from 140 patients and found that by age 10, many had experienced up to 9 different health problems, and about 64% had received some form of treatment by that age. Unfortunately, the study also noted 13 deaths over an average follow-up period of 2.6 years, showing how severe and life-threatening this disease can be. Who this helps: This information helps doctors and researchers better understand the challenges faced by patients with APDS.

Plain English
This study looked at how a bacterium called MAB, which can cause severe lung infections in people with cystic fibrosis, forms protective clusters known as biofilms. Researchers found that specific changes in MAB, driven by the chemical environment of cystic fibrosis mucus, led to increased production of certain metabolites, which in turn boosted biofilm formation and made the bacteria more resistant to antibiotics. By adding acetate to the bacteria’s environment, they were able to promote more biofilm growth without triggering the same regulatory changes, indicating a direct link between these metabolites and biofilm formation. Who this helps: This helps patients with cystic fibrosis by providing insights into better treatments for their infections.

Plain English
This research examined how certain bacteria, known as Pseudomonadota, interact with nematodes (tiny roundworms) in the soil to help reduce diseases in plants. The study found that areas where nematodes and Pseudomonadota were closely associated had less bacterial wilt disease, and when nematodes were present in lab experiments, they helped increase Pseudomonadota while reducing harmful bacteria by over 95%. This is important because it shows how these interactions can be used to control soil diseases naturally, providing a new way to protect crops. Who this helps: Farmers and agricultural scientists looking for natural ways to manage plant diseases.

Plain English
This study looked at how leniolisib, a new oral medication, compares to the usual treatment for people with activated PI3Kδ syndrome, a rare immune disorder. It found that those taking leniolisib experienced a significant drop in respiratory tract infections by about two-thirds (annual infection rate reduced to 34% of what it was) and a notable decrease in a key immune protein, serum IgM, by over 1 gram per liter. These results matter because they suggest that leniolisib may improve the immune function of patients and lower their risk of infections, which could lead to fewer complications in their treatment. Who this helps: This benefits patients with activated PI3Kδ syndrome.

Plain English
Researchers successfully transported a new type of highly accurate clock, called the ytterbium transportable optical lattice clock (Yb TOLC), over 3000 kilometers from Colorado to Washington, D.C. After just two days, the clock was fully operational and could be used to make precise time comparisons with another clock at the United States Naval Observatory. This development is significant because it demonstrates that these advanced clocks can be easily moved and set up, potentially improving timekeeping standards used in various scientific fields. Who this helps: This benefits researchers, scientists, and institutions that rely on precise time measurements.

Plain English
This study looked at how people used integrative medicine services at a health center in Colorado from 2011 to 2022. Over this period, the center had almost 96,000 visits from about 15,000 adults, with many patients seeking help for chronic pain, mental health issues, and obesity. Most of the patients were white, female, and had commercial insurance, showing a clear demand for holistic treatments like acupuncture and massage. Who this helps: This benefits patients seeking alternative therapies for various health problems.

Plain English
A study looked at an 18-year-old man with seizures linked to a brain tumor in his right temporal lobe. Imaging showed that the amygdala, a part of the brain involved in emotions and responses to stress, was enlarged but did not have cancerous cells—it was simply reacting to the situation. This finding is important because it helps doctors differentiate between benign growth and actual tumor spread, which can guide better surgical treatment decisions. Who this helps: This helps patients with seizures and their doctors in making informed decisions about surgery.

Plain English
This study looked at a new scoring system called the 2HELPS2B seizure risk score to help manage how long critically ill patients should be monitored for seizures with EEG. The research involved 552 patients, and after using this score, monitoring times were significantly reduced for low-risk patients (from 36.3 to 23.8 hours) and moderate-risk patients (from 36.5 to 29.3 hours) without affecting seizure detection rates. This matters because it helps hospitals use resources more efficiently while still monitoring patients adequately for seizures. Who this helps: This benefits patients in intensive care and improves care management for doctors.

Plain English
This study looked at the challenges American Indian and Alaska Native (AI/AN) communities face when accessing healthcare, especially specialty care and clinical trials. It found that these communities grapple with significant barriers, including a lack of trust in the healthcare system due to historical experiences, leading to unmet health needs. Addressing these issues is crucial for improving health equity and ensuring that AI/AN individuals receive the care they need, given their increased risk for serious health conditions like cancer. Who this helps: This helps patients in American Indian and Alaska Native communities.

Plain English
This study looked at how different sizes of microplastics affect the immune cells of earthworms, specifically how well these cells can engulf (or phagocytize) the microplastics. It found that earthworm immune cells swallowed 85% of the smaller microplastics (1-10 micrometers), but hardly touched the larger ones (20-27 micrometers). Additionally, exposure to the small microplastics reduced cell health to just 6-7%, compared to 94% for cells not exposed to microplastics. This research is important because it shows that smaller microplastics can harm earthworm health more than larger ones, affecting soil health and ecosystems. Who this helps: This helps farmers and environmentalists by highlighting the risks microplastics pose to soil health.

Plain English
Researchers studied the effects of Activated Phosphoinositide 3-Kinase δ Syndrome (APDS) on the quality of life for patients. They found that people with APDS experienced a significant decline in their health-related quality of life, especially those with multiple symptoms or diagnosed with lymphoma, with utility values ranging from 0.897 to -0.109. These findings highlight the severe impact of this rare disease on daily living and emphasize the need for better understanding and support for affected individuals. Who this helps: Patients and their families living with APDS.

Plain English
This study looked at why some patients with diffuse large B-cell lymphoma (DLBCL) don’t respond well to a specific type of treatment known as CAR T-cell therapy. Researchers found that even when DLBCL cells lose the target marker (CD19), this doesn’t predict their sensitivity to the treatment, and that these resistant cells show specific gene patterns that can indicate how well a patient will respond to therapy. They also identified combination strategies, like targeting multiple cell markers at once, which could lead to better treatment outcomes. Who this helps: This helps patients with DLBCL who are undergoing CAR T-cell therapy.

Plain English
This study looked at how certain nutrients, specifically nitrogen and carbon, affect the way harmful bacteria form biofilms, which help them stick to surfaces like plumbing. Researchers found that when nitrogen is available, levels of a substance called glutamine increase, and this increase is linked to how well the bacteria grow and form clusters. They discovered that altering specific genes related to glutamine impacts the bacteria's ability to clump together, which is crucial for understanding and potentially stopping infections caused by these bacteria. Who this helps: This research benefits patients at risk of infections from nontuberculous mycobacteria and the doctors treating them.

Plain English
This study looked at how a nutrient called glutamine affects the formation of biofilms by certain bacteria known as nontuberculous mycobacteria (NTM), which can cause serious infections. Researchers found that when nitrogen levels are high, the amount of glutamine inside the bacteria increases, which seems to help them stick together in biofilms; specifically, they noted that alterations in glutamine levels impacted how these bacteria aggregated. Understanding this relationship could lead to better ways to prevent and treat infections caused by these bacteria, especially since biofilm formation makes them more resistant to antibiotics. Who this helps: This helps patients at risk of NTM infections, as well as doctors looking for effective treatments.

Plain English
This study looked at how large pieces of plastic in the soil affect growing maize (corn) plants and the ways nitrogen, an essential nutrient, behaves in the soil. The researchers found that while the visible parts of maize plants didn't change much, the roots were stunted and nitrogen was not effectively used. Specifically, there was less nitrogen available for the plants and an increase in bacteria that can cause nitrogen loss. This matters because it highlights how plastic pollution can affect soil health and crop production, which may lead to greater fertilizer use without benefits for farmers. Who this helps: This helps farmers and agricultural scientists working to improve crop yields sustainably.

Plain English
This study looked at combining a drug called ianalumab with ibrutinib in patients with chronic lymphocytic leukemia (CLL) who were not fully responding to ibrutinib therapy. Out of 39 patients, 38.5% achieved a significant improvement in their condition by cycle 9, with 43.6% showing no remaining cancer cells in their blood or bone marrow. This matters because it offers a potential new treatment option for patients who struggle with existing therapies, enhancing their chances of recovery. Who this helps: This helps patients with chronic lymphocytic leukemia who have not responded well to current treatments.

Plain English
This study looked at how certain chemicals found in everyday products (like phthalates and parabens) affect hormone levels in pregnant women. The researchers found that higher levels of these chemicals were linked to lower testosterone and thyroid-stimulating hormone (TSH) levels, with specific increases leading to about 5.65% lower testosterone and 0.09 µIU/mL lower TSH. This is important because it helps us understand how exposure to these chemicals might impact pregnancy and fetal development. Who this helps: This helps pregnant women and their healthcare providers understand potential risks to hormonal health during pregnancy.

Plain English
This study looked at how certain chemicals found in many consumer products, called PFAS, affect the health of pregnant women around the middle of their pregnancy. Researchers tested 452 women and found that higher levels of PFAS were linked to lower insulin, lower risk of insulin resistance, and increased good cholesterol (HDL) levels. For instance, a 25% increase in PFAS levels led to over a 30% drop in insulin and insulin resistance measures, which could help in understanding how these chemicals impact maternal and fetal health. Who this helps: This helps pregnant women and healthcare providers understand potential risks associated with PFAS exposure.

Plain English
This study looked at how certain chemicals known as PFAS, found in the environment, affect hormone levels in pregnant women during the early second trimester. Researchers found that higher levels of PFOS were linked to increases in progesterone (about 3% more) and estradiol (about 8% more), while PFHxS was associated with a 10% rise in testosterone; however, other PFAS like PFDeA and PFUdA were linked to lower testosterone levels. Understanding these associations is important because hormones play a crucial role in maintaining a healthy pregnancy and fetal development. Who this helps: This information can help doctors monitor and manage the health of pregnant women.

Plain English
This study focused on activated phosphoinositide 3-kinase delta syndrome (APDS), a rare immunodeficiency affecting only 256 people worldwide. Researchers interviewed people with APDS, their caregivers, and healthcare providers to understand how the condition impacts daily life and well-being. They found that APDS leads to serious health problems like frequent infections and fatigue, drastically affecting daily activities, emotional health, and relationships for both patients and caregivers. The results highlight the need for better treatments specifically designed to help manage APDS. Who this helps: This information benefits patients with APDS and their caregivers by highlighting their challenges and the need for improved medical support.

Plain English
This study looks at how cells manage problems when DNA replication goes wrong, specifically with long repeats of certain DNA sequences called CAG/CTG. The researchers found that when DNA replication stops, a checkpoint system in the cell helps move these problematic DNA regions to the edge of the nucleus to protect them. They discovered that specific proteins need to be activated for this relocation to happen, highlighting the importance of the DNA damage response in maintaining DNA integrity. Who this helps: This benefits patients with genetic disorders linked to DNA replication issues, as it could lead to better understanding and potential treatments.

Plain English
This study looked at how the diets of pregnant women affect their health and whether better diets lead to lower levels of harmful chemicals called phthalates in their bodies. Researchers found that a better diet, measured by a score called the Alternative Healthy Eating Index, was linked to lower levels of body fat and inflammation markers. Specifically, every 10-point improvement in diet quality led to a 15% decrease in body fat scores and an 18% reduction in phthalate levels. This matters because reducing phthalate exposure during pregnancy can help improve the health of both mothers and their babies. Who this helps: Pregnant women and their healthcare providers.

Plain English
This study focused on understanding and treating core muscle injuries in athletes, which often cause groin pain. The research found that dynamic imaging, like ultrasound, can help diagnose these injuries, and if non-surgical treatments fail after about 12 weeks, surgery may be necessary. For athletes undergoing surgery for a core muscle injury, they can typically return to play in about four weeks, while those with additional procedures may take up to 12 weeks to recover. Who this helps: This information benefits athletes experiencing groin pain, as well as the doctors diagnosing and treating these injuries.

Plain English
This study focused on creating and testing a specific questionnaire called the Fibrodysplasia Ossificans Progressiva Physical Function Questionnaire (FOP-PFQ) to measure how the rare disease FOP affects people's physical abilities and daily activities. The research found that this survey is reliable and valid, with scores showing high consistency over time and strong relationships with other health measures, indicating that it effectively reflects the impact of the disease. This matters because it provides a useful tool for assessing the physical challenges faced by individuals with FOP, which can guide treatment and support. Who this helps: This helps patients with FOP and their healthcare providers.

Plain English
This study compared two types of botulinum toxin treatments—abobotulinumtoxinA (aboBoNT-A) and onabotulinumtoxinA (onaBoNT-A)—for managing refractory neurogenic detrusor overactivity, a condition causing uncontrollable bladder contractions. While both treatments showed similar results in reducing urinary incontinence episodes, abobotulinumtoxinA at a higher dose (800 units) appeared to perform slightly better than onabotulinumtoxinA (200 units) after 12 and 24 weeks. This matters because finding more effective treatments can improve the quality of life for patients struggling with this challenging condition. Who this helps: Patients suffering from refractory neurogenic detrusor overactivity.

Plain English
Researchers studied the presence of a condition called clonal hematopoiesis (CH) in cancer patients using a method that examines DNA from blood samples, rather than requiring separate tumor samples. They found that 30.3% of the 4,324 cancer patients tested showed evidence of CH, which is linked to increased inflammation and poorer outcomes, especially in patients with certain types of tumors. This matters because it provides a new way to identify patients at higher risk for severe complications, allowing for better treatment planning and monitoring. Who this helps: This helps patients and doctors by improving risk assessment and management in cancer care.

Plain English
This study looked at the effects and costs of two different treatments for limb spasticity given to adults at a rehabilitation center in the UK. It compared the traditional treatment (onabotulinumtoxinA) used from 2015 to 2017 with a newer one (abobotulinumtoxinA) used from 2017 to 2019. They found that patients treated with abobotulinumtoxinA had slightly better goal achievement scores after six weeks and improved quality of life by week twelve, while treatment costs were lower for the newer drug (around £249 compared to £316 for the older treatment). Who this helps: This helps patients with limb spasticity and their doctors by providing insight into more effective and cost-efficient treatment options.

Plain English
Researchers created a new tool called the Spasticity-related Quality of Life 6-Dimensions instrument (SQoL-6D) to better understand how upper limb spasticity affects patients' lives. They tested this tool on 104 adults receiving treatment, finding that it effectively measured changes in their health status, showing an average improvement of 0.51 points for those feeling "some benefit" and 0.88 points for those feeling a "great benefit" within eight weeks. This matters because it helps doctors assess the impact of treatments on patients based on their personal health goals. Who this helps: This helps patients with upper limb spasticity and their healthcare providers.

Plain English
This study evaluated a new tool called the Spasticity-related Quality of Life 6-Dimensions instrument (SQoL-6D) designed to measure the impact of upper-limb spasticity on patients' lives. Researchers tested the SQoL-6D on 104 adult patients and found it to be reliable and valid, with a good internal consistency score of 0.74 and a test-retest reliability score of 0.82. This tool is important because it can help better understand how upper-limb spasticity affects patients' health and quality of life, potentially guiding treatment decisions. Who this helps: Patients with upper-limb spasticity and their healthcare providers.

Plain English
This study looked at how often NFL players experience a specific type of hip injury called traumatic posterior hip instability over 18 seasons from 2000 to 2017. There were 16 injuries reported, affecting 14 players, with the highest number (4 injuries) occurring in 2013. The average recovery time was about 137 days, and players who needed surgery missed more time than those who didn't. Understanding this injury better is important for improving player safety and recovery methods. Who this helps: This information helps NFL players and teams in managing injuries better.

Plain English
Researchers studied the impact of wastewater from a mining facility on Tampa Bay's water quality after a large spill in April 2021. They found that nearly 814 million liters of wastewater added 186 metric tons of nitrogen to the bay in just a few days, which led to harmful algal blooms that resulted in the deaths of over 1,600 metric tons of fish. This is important because it shows how quickly a significant pollution event can damage aquatic life and water conditions. Who this helps: This helps environmental agencies and local communities concerned about water health and marine life.

Plain English
This research studied how certain compounds might protect against Alzheimer’s Disease (AD) triggered by the herpes virus. The scientists tested 21 different substances and found that green tea catechins and resveratrol were particularly effective at reducing plaque buildup in the brain, which is a key sign of AD, while being safe for neurons. Citicoline and metformin also showed some promise by reducing plaque formation but did not help with other issues caused by the virus. Who this helps: This benefits patients with Alzheimer’s and their caregivers by exploring potential new treatments.

Plain English
This study compared two treatments, abobotulinumtoxinA (Dysport) and onabotulinumtoxinA (Botox), for managing muscle stiffness and related conditions in children and adults. Researchers found that using Dysport led to better quality of life and cost savings of £304 to £3,963 while gaining 0.010 to 0.02 quality-adjusted life years (QALYs) in one year compared to Botox. This matters because it suggests that Dysport may be a more effective and economical option for patients needing these treatments. Who this helps: Patients with muscle stiffness, their families, and healthcare providers.

Plain English
This study looked at why families call for help after their children have had outpatient urologic surgery. Out of 1,618 patients, 460 (or about 28%) made at least one call in the month following surgery, averaging 1.5 calls each. Families living farther away or not speaking English as their first language, as well as Native American or Alaskan Native families, were less likely to call, while those with commercial insurance and those whose children had certain types of penile surgery were more likely to contact the hospital. Who this helps: This information benefits healthcare providers trying to improve support for families after surgery.

Plain English
Researchers studied how different winter survival conditions affect pest populations, specifically looking at a common pest called Boddie across North America. They found that populations are increasing, especially in warmer southern areas, which have seen a 3% expansion since 1981 and could double by 2099. This is important because as these pests survive better in colder regions, farmers may face larger infestations, affecting crop yields. Who this helps: Farmers and agricultural planners.

Plain English
This study examined the long-term benefits of treating spasticity (muscle stiffness) after a stroke with a combination of a drug called AbobotulinumtoxinA and rehabilitation therapy. The results indicated that this combined treatment reduced the risk of death from all causes by 8.8%, increased life expectancy by 13%, and improved quality of life by 59% compared to just rehabilitation therapy alone. This matters because it shows that using AbobotulinumtoxinA can enhance recovery after a stroke while also being a cost-effective option. Who this helps: Patients recovering from strokes who experience spasticity.

Plain English
This study examined how well certain pests, specifically the cotton bollworm (Helicoverpa zea), are resisting Bt toxins in sweet corn crops across the U.S. and Canada. Researchers set up 73 sweet corn trials over three years and found that damage from these pests has increased significantly, indicating they are becoming more resistant to Cry toxins, with some evidence of lower susceptibility to another toxin called Vip3A. This matters because understanding how pests evolve resistance helps farmers manage their crops better and can influence pest control strategies to protect harvests. Who this helps: Farmers and agricultural professionals working with Bt crops.

Plain English
This study looked at how effective and safe various treatments are for patients with advanced epithelioid sarcoma, a rare and aggressive cancer, by reviewing medical records from five cancer centers. Among the 74 patients analyzed, the first-line treatments helped only a small number, with a 15% response rate and patients typically living around 15 months after starting therapy. Importantly, many patients faced significant side effects, highlighting the limited benefits versus risks of these treatments. Who this helps: This research benefits doctors and patients exploring treatment options for advanced epithelioid sarcoma.

Plain English
This study reviewed many research papers to understand how being shorter than average affects the quality of life for both children and adults. It found that children with short stature, especially those with specific medical conditions, generally reported a much lower quality of life, with studies showing this difference in at least four cases. For adults, the results were mixed, with some showing a reduced quality of life due to short stature, and others not finding a significant link. Who this helps: This helps patients with short stature and their families, as well as doctors looking to better address their needs.

Plain English
This research paper looks at epidermolysis bullosa (EB), a rare genetic skin condition that makes skin very fragile. It highlights that diagnosing EB now relies more on genetic tests rather than just looking at symptoms. Key findings include updated recommendations for how to care for newborns with EB and the importance of educating families about managing the condition and transitioning from hospital to home care. Who this helps: This helps newborns with epidermolysis bullosa and their families.

Plain English
This study looked at two types of botulinum toxin treatments, AbobotulinumtoxinA (aboBoNT-A) and OnabotulinumtoxinA (onaBoNT-A), used to treat children with muscle stiffness in their arms. Researchers found that aboBoNT-A had a higher success rate and improved quality of life for patients while being less expensive, costing about £39,056 per successful outcome compared to £54,831 for onaBoNT-A. This matters because it shows that choosing aboBoNT-A can lead to better health benefits and lower costs for families and healthcare systems. Who this helps: This benefits children with upper limb spasticity and their families.

Plain English
This study looked at how cells in yeast finish their division, focusing on a protein called Nud1 that helps manage when the cell should exit the dividing phase. Researchers discovered a version of Nud1 that works too quickly, causing problems by allowing the division to proceed even when the cell's components are not properly positioned, which could lead to issues in the genetic material. This matters because controlling the timing of cell division is essential for maintaining genetic integrity and preventing errors that could lead to diseases. Who this helps: This helps researchers and doctors understand cell division better, potentially guiding cancer treatments where cell division goes awry.

Plain English
This study looked at how a specific surgical procedure, called adductor longus release, helps elite athletes with chronic groin pain recover and return to their sport. Out of 32 athletes who had the surgery, 97% were able to return to their sport, and 94% went back to playing at the same level they were before the injury, with an average recovery time of 12 weeks. The findings highlight that this surgery is effective in relieving groin pain and helping athletes get back to their game, which is crucial for their careers. Who this helps: This helps athletes, especially those in college sports and professional football, who suffer from persistent groin injuries.

Plain English
This study examined the challenges related to the use of trastuzumab biosimilars—medications similar to the original trastuzumab for treating HER2-positive breast cancer. While five biosimilars were approved by the FDA by the end of 2019, only two are actually available on the market. The research found that issues like lack of education for providers and patients, concerns about safety and effectiveness, and high costs are hindering broader adoption of these potentially cheaper treatment options. Who this helps: This helps patients with HER2-positive breast cancer who may benefit from more affordable treatment options.

Plain English
This study looked at how effective certain laboratory tests are in diagnosing septic arthritis in patients with weakened immune systems. Researchers analyzed data from 33 such patients and found that the common benchmark of 50,000 cells per mm for synovial fluid was not a reliable indicator, as only 31% of patients had fluid counts above that level. These findings indicate that doctors might need to reconsider how they diagnose septic arthritis in these vulnerable patients to avoid misdiagnosis. Who this helps: This helps doctors and healthcare providers working with immunosuppressed patients.

Plain English
This research studied patients suspected of having septic arthritis to see if laboratory tests could reliably diagnose the condition. Among 65 patients, 40 (61.5%) were confirmed to have septic arthritis, showing that those with the infection had a higher percentage of certain white blood cells called neutrophils. However, other lab tests and cell counts did not effectively distinguish between infected and non-infected individuals, which is critical because accurate diagnosis is necessary for timely treatment and reducing joint damage. Who this helps: This study helps doctors by identifying the limits of current laboratory tests in diagnosing septic arthritis, aiding in better decision-making for patient care.

Plain English
This study examined the effectiveness and safety of a new oral medication called tazemetostat for patients with follicular lymphoma, a type of cancer that often returns after treatment. In a group of 99 patients, those with a specific genetic mutation (EZH2) saw a response rate of 69%, while those without the mutation had a response rate of 35%. This research matters because it shows that tazemetostat can provide significant and lasting benefits for patients who have not responded to other treatments. Who this helps: This helps patients with relapsed or refractory follicular lymphoma, especially those with the EZH2 mutation.

Plain English
This study examined two methods of keeping patients warm during total hip and knee surgeries: the traditional forced-air warming and a new approach that combines preoperative forced-air warming with a special warming mattress during surgery. After reviewing the charts of 769 patients, it was found that the new method led to higher average body temperatures and fewer instances of hypothermia in the first group of patients who received it (12.9% vs. 7.7%). This is important because maintaining a stable body temperature during surgery can reduce complications and improve recovery outcomes. Who this helps: This benefits patients undergoing joint replacement surgeries.